Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

Most nuclear medicine technologists are employed in hospital settings, where they contribute to the diagnosis and treatment.

Telix Pharmaceuticals Limited today announces that it has received a positive decision on the Marketing Authorization ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...

Chief minister Sukhvinder Singh Sukhu says HIMCARE scheme is operational in all government hospitals of the state. “The BJP ...

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

Before treatment, patients need a diagnosis confirmed by a hi-tech PET scan or a lumbar puncture ... the new drugs could instead be delivered by injection beneath the skin, opening the door ...

CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Multikine is designed to help the immune system "target" the ...

Multikine (Leukocyte Interleukin, Injection), a true first-line cancer ... patients with no lymph node involvement (determined via PET scan) and with low PD-L1 tumor expression (determined via ...

Multikine (Leukocyte Interleukin, Injection), a true first-line cancer ... patients with no lymph node involvement (determined via PET scan) and with low PD-L1 tumor expression (determined via ...